A grafted kidney after kidney transplantation
via Arizona Transplant Associates
Regenerative medicine researchers at Wake Forest Baptist Medical Center have addressed a major challenge in the quest to build replacement kidneys in the lab.
Working with human-sized pig kidneys, the scientists developed the most successful method to date to keep blood vessels in the new organs open and flowing with blood. The work is reported in journal Technology.
“Until now, lab-built kidneys have been rodent-sized and have functioned for only one or two hours after transplantation because blood clots developed,” said Anthony Atala, M.D., director and professor at the Wake Forest Institute for Regenerative Medicine and a senior author on the study. “In our proof-of-concept study, the vessels in a human-sized pig kidney remained open during a four-hour testing period. We are now conducting a longer-term study to determine how long flow can be maintained.”
If proven successful, the new method to more effectively coat the vessels with cells (endothelial) that keep blood flowing smoothly, could potentially be applied to other complex organs that scientists are working to engineer, including the liver and pancreas.
The current research is part of a long-term project to use pig kidneys to make support structures known as “scaffolds” that could potentially be used to build replacement kidneys for human patients with end-stage renal disease. Scientists first remove all animal cells from the organ – leaving only the organ structure or “skeleton.” A patient’s own cells would then be placed in the scaffold, making an organ that the patient theoretically would not reject.
The Latest on: Replacement kidneys
via Google News
The Latest on: Replacement kidneys
- Dapagliflozin safe in hospitalized patients with COVID-19 with preserved or reduced kidney functionon April 30, 2022 at 5:26 am
kidney replacement therapy, or death. "These new data from DARE-19 reinforce the safety of dapagliflozin in acutely ill patients hospitalized with COVID-19 even in those with reduced kidney function ...
- Does the drug dapagliflozin benefit hospitalized patients with COVID-19?on April 28, 2022 at 2:01 pm
kidney replacement therapy, or death. "These new data from DARE-19 reinforce the safety of dapagliflozin in acutely ill patients hospitalized with COVID-19 even in those with reduced kidney ...
- Acute kidney injury among pediatric COVID-19 patients admitted to the ICU in North Americaon April 28, 2022 at 4:34 am
In a recent study published in PLoS ONE, researchers analyzed acute kidney injury (AKI) in coronavirus disease 2019 (COVID-19) pediatric patients.
- Continuous Renal Replacement Therapy Market is likely to grow at a CAGR of 7.7% through 2027, reaching US$ 1.68 Billion.on April 26, 2022 at 7:41 pm
Pages Report] Acute kidney injury (AKI) is a common type of kidney disorder with high morbidity and mortality worldwide. Patients from low-resource regions are more prone to acute kidney injuries. The ...
- Medical Compass: Love your kidneys and they will love you backon April 24, 2022 at 6:23 am
Your kidneys function as efficient little blood filters. They remove wastes, toxins and excess fluid from the body. In addition, they play roles in controlling blood pressure, producing red blood ...
- Continuous Renal Replacement Therapy Market is likely to grow at a CAGR of 7.7% through 2027on April 20, 2022 at 10:46 pm
Pages Report] Acute kidney injury (AKI) is a common type of kidney disorder with high morbidity and mortality worldwide. Patients from low-resource regions are more prone to acute kidney injuries. The ...
- Global Continuous Renal Replacement Therapy (CRRT) Market Analysis Report 2022-2030on April 19, 2022 at 4:43 am
The "Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report by Product (System, Consumables), by Modality (Slow Continuous Ultra-Filtration, Continuous Veno-Venous ...
- Global Continuous Renal Replacement Therapy (CRRT) Market to Reach $1.7 Billion by 2026'on April 18, 2022 at 3:38 pm
Continuous renal replacement therapy (CRRT) is the most widely used therapy in critically ill patients as these hypotensive patients require slow removal of waste and water without causing ...
- Renal Replacement Therapy Market 2022 Insights & Forecast Research Report 2028on April 13, 2022 at 7:56 am
Apr 13, 2022 (Market Insight Reports) -- Selbyville, Delaware. A recent Renal Replacement Therapy Market from 2022 to 2028 search undertaken by Market Study Report provides a complete picture of ...
- Continuous Renal Replacement Therapy Market Worth $2.6 Billion by 2030: Grand View Research, Inc.on April 12, 2022 at 3:04 am
SAN FRANCISCO, April 11, 2022 /PRNewswire/ -- The global continuous renal replacement therapy market size is anticipated to reach USD 2.6 billion by 2030, according to a new report by Grand View ...
via Bing News
